(BCAT) BlackRock Capital - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US09260U1097
Stock:
Total Rating 47
Risk 62
Buy Signal -0.31
| Risk 5d forecast | |
|---|---|
| Volatility | 12.9% |
| Relative Tail Risk | 0.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.34 |
| Alpha | 9.71 |
| Character TTM | |
|---|---|
| Beta | 0.606 |
| Beta Downside | 0.816 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.69% |
| CAGR/Max DD | 1.44 |
EPS (Earnings per Share)
Revenue
Description: BCAT BlackRock Capital
Headlines to watch out for
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 222.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA -0.56 > 1.0 |
| NWC/Revenue: -120.1% < 20% (prev -69.81%; Δ -50.33% < -1%) |
| CFO/TA 0.17 > 3% & CFO 329.5m > Net Income 222.0m |
| Net Debt (-6.75m) to EBITDA (222.0m): -0.03 < 3 |
| Current Ratio: 0.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (104.8m) vs 12m ago -2.50% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 11.21% > 50% (prev 9.65%; Δ 1.56% > 0%) |
| Interest Coverage Ratio: 155.5 > 6 (EBITDA TTM 222.0m / Interest Expense TTM 1.43m) |
Altman Z'' 4.67
| A: -0.14 (Total Current Assets 6.75m - Total Current Liabilities 277.1m) / Total Assets 1.97b |
| B: 0.09 (Retained Earnings 186.2m / Total Assets 1.97b) |
| C: 0.11 (EBIT TTM 222.0m / Avg Total Assets 2.01b) |
| D: 4.31 (Book Value of Equity 1.60b / Total Liabilities 370.4m) |
| Altman-Z'' Score: 4.67 = AA |
Beneish M
| DSRI: none (Receivables none/30.2m, Revenue 225.0m/197.7m) |
| GMI: 1.01 (GM 99.37% / 100.0%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.14 (Revenue 225.0m / 197.7m) |
| TATA: -0.05 (NI 222.0m - CFO 329.5m) / TA 1.97b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of BCAT shares?
As of March 18, 2026, the stock is trading at USD 14.67 with a total of 881,600 shares traded.
Over the past week, the price has changed by -1.64%, over one month by +0.88%, over three months by +11.00% and over the past year by +23.25%.
Over the past week, the price has changed by -1.64%, over one month by +0.88%, over three months by +11.00% and over the past year by +23.25%.
Is BCAT a buy, sell or hold?
BlackRock Capital has no consensus analysts rating.
What are the forecasts/targets for the BCAT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
BCAT Fundamental Data Overview March 16, 2026
P/E Trailing = 6.8962
P/S = 6.8505
P/B = 0.9602
Revenue TTM = 225.0m USD
EBIT TTM = 222.0m USD
EBITDA TTM = 222.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -6.75m USD (from netDebt column, last quarter)
Enterprise Value = 1.53b USD (1.53b + (null Debt) - CCE 6.75m)
Interest Coverage Ratio = 155.5 (Ebit TTM 222.0m / Interest Expense TTM 1.43m)
EV/FCF = 4.63x (Enterprise Value 1.53b / FCF TTM 329.5m)
FCF Yield = 21.61% (FCF TTM 329.5m / Enterprise Value 1.53b)
FCF Margin = 146.4% (FCF TTM 329.5m / Revenue TTM 225.0m)
Net Margin = 98.65% (Net Income TTM 222.0m / Revenue TTM 225.0m)
Gross Margin = unknown ((Revenue TTM 225.0m - Cost of Revenue TTM 1.43m) / Revenue TTM)
Tobins Q-Ratio = 0.78 (Enterprise Value 1.53b / Total Assets 1.97b)
Interest Expense / Debt = unknown (Interest Expense 1.43m / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 175.4m (EBIT 222.0m * (1 - 21.00%))
Current Ratio = 0.02 (Total Current Assets 6.75m / Total Current Liabilities 277.1m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.03 (Net Debt -6.75m / EBITDA 222.0m)
Debt / FCF = -0.02 (Net Debt -6.75m / FCF TTM 329.5m)
Total Stockholder Equity = 1.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.06% (Net Income 222.0m / Total Assets 1.97b)
RoE = 12.96% (Net Income TTM 222.0m / Total Stockholder Equity 1.71b)
RoCE = 13.15% (EBIT 222.0m / Capital Employed (Total Assets 1.97b - Current Liab 277.1m))
RoIC = 13.20% (EBIT 222.0m / (Assets 1.97b - Curr.Liab 277.1m - Cash 6.75m))
WACC = 8.15% (E(1.53b)/V(1.53b) * Re(8.15%) + (debt-free company))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -1.26%
[DCF] Terminal Value 76.66% ; FCFF base≈339.7m ; Y1≈320.8m ; Y5≈303.1m
[DCF] Fair Price = 50.05 (EV 5.24b - Net Debt -6.75m = Equity 5.24b / Shares 104.8m; r=8.15% [WACC]; 5y FCF grow -7.15% → 2.90% )
EPS Correlation: -46.77 | EPS CAGR: -94.86% | SUE: N/A | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: 0.0% | SUE: N/A | # QB: 0
P/S = 6.8505
P/B = 0.9602
Revenue TTM = 225.0m USD
EBIT TTM = 222.0m USD
EBITDA TTM = 222.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -6.75m USD (from netDebt column, last quarter)
Enterprise Value = 1.53b USD (1.53b + (null Debt) - CCE 6.75m)
Interest Coverage Ratio = 155.5 (Ebit TTM 222.0m / Interest Expense TTM 1.43m)
EV/FCF = 4.63x (Enterprise Value 1.53b / FCF TTM 329.5m)
FCF Yield = 21.61% (FCF TTM 329.5m / Enterprise Value 1.53b)
FCF Margin = 146.4% (FCF TTM 329.5m / Revenue TTM 225.0m)
Net Margin = 98.65% (Net Income TTM 222.0m / Revenue TTM 225.0m)
Gross Margin = unknown ((Revenue TTM 225.0m - Cost of Revenue TTM 1.43m) / Revenue TTM)
Tobins Q-Ratio = 0.78 (Enterprise Value 1.53b / Total Assets 1.97b)
Interest Expense / Debt = unknown (Interest Expense 1.43m / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 175.4m (EBIT 222.0m * (1 - 21.00%))
Current Ratio = 0.02 (Total Current Assets 6.75m / Total Current Liabilities 277.1m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.03 (Net Debt -6.75m / EBITDA 222.0m)
Debt / FCF = -0.02 (Net Debt -6.75m / FCF TTM 329.5m)
Total Stockholder Equity = 1.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.06% (Net Income 222.0m / Total Assets 1.97b)
RoE = 12.96% (Net Income TTM 222.0m / Total Stockholder Equity 1.71b)
RoCE = 13.15% (EBIT 222.0m / Capital Employed (Total Assets 1.97b - Current Liab 277.1m))
RoIC = 13.20% (EBIT 222.0m / (Assets 1.97b - Curr.Liab 277.1m - Cash 6.75m))
WACC = 8.15% (E(1.53b)/V(1.53b) * Re(8.15%) + (debt-free company))
Discount Rate = 8.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -1.26%
[DCF] Terminal Value 76.66% ; FCFF base≈339.7m ; Y1≈320.8m ; Y5≈303.1m
[DCF] Fair Price = 50.05 (EV 5.24b - Net Debt -6.75m = Equity 5.24b / Shares 104.8m; r=8.15% [WACC]; 5y FCF grow -7.15% → 2.90% )
EPS Correlation: -46.77 | EPS CAGR: -94.86% | SUE: N/A | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: 0.0% | SUE: N/A | # QB: 0